Skip to main content

Pear Therapeutics

Our Science For Clinicians For Payers Who We Are Newsroom Contact

Request a Prescription

Contact

Talk with our team

Whether you prescribe, pay for, or evaluate treatment, we can point you to the right information.

Full name

Email

I am a

How can we help?

Please do not include personal health information in this form.

Clinical & prescribing

Indications, prescribing logistics, and patient onboarding support.

Payers & partnerships

Coverage, pilot design, and outcomes reporting discussions.

Headquarters

Boston, Massachusetts, United States

Prescribe a PDT

Clinicians can learn how to prescribe reSET® and reSET-O™ for their patients.

Review the Evidence

Explore the clinical trials behind our prescription digital therapeutics.

Partner With Pear

Payers and health systems: cost-effective solutions with measurable outcomes.

Pear Therapeutics

The leader in FDA-cleared prescription digital therapeutics — combining clinically-validated software with established pharmaceuticals and treatment paradigms.

Products

reSET® for SUD
reSET-O™ for OUD
Product Pipeline
Our Science

Audiences

For Clinicians
For Payers
For Patients
Contact Us

Company

Who We Are
Newsroom
Pipeline

Pear Insights Newsletter

Clinical evidence, pipeline milestones, and prescription digital therapeutic news — delivered occasionally. No medical advice, no spam.

Email address

I agree to receive marketing emails from Pear Therapeutics and accept the Privacy Policy. You can unsubscribe at any time. *

reSET® and reSET-O™ are prescription-only digital therapeutics intended for use as adjuncts to outpatient treatment. THRIVE™, reCALL™, and reVIVE™ are investigational products for which Pear intends to obtain FDA clearance and are not available for prescription. This website is for informational purposes and is not a substitute for medical advice.

© 2026 Pear Therapeutics. All rights reserved.

Privacy Policy|
Terms of Use|
Accessibility